27th Jul 2015 11:37
LONDON (Alliance News) - Allergy Therapeutics PLC Monday said Chief Executive Officer Manuel Llobet bought 50,000 shares at a price of 24.45 pence per share Friday.
Following this transaction, Llobet's beneficial holding now stands at 3.2 million shares, which represents 0.58% of the issued share capital.
The purchase came after Allergy Therapeutics on Thursday said it expects to post revenue growth of 11% for its recently ended financial year at constant currency, although its reported figures will be hit the weakening of the euro.
The specialist pharmaceutical company expects to post revenue at constant currency of GBP46.6 million for the year to end-June, compared to GBP42.0 million a year before. At actual exchange rates it expects to post revenue of GBP43.2 million, which it said is "slightly ahead of analyst expectations."
Shares in the research and development company were up 2.7% at 25.42p Monday.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Allergy Thera.